Stable hydrolysis-resistant synthetic Polyribosylribitolphosphate derivates as 
vaccines against Haemophilus influenzae type b

Seeberger, Peter H.

Lokale TagsFreigabegeschichteDetailsÜbersicht

Stable hydrolysis-resistant synthetic Polyribosylribitolphosphate derivates as vaccines against Haemophilus influenzae type b

Seeberger, P. H.(2018). Stable hydrolysis-resistant synthetic Polyribosylribitolphosphate derivates as vaccines against Haemophilus influenzae type b.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/21.11116/0000-0000-740E-F Versions-Permalink: https://hdl.handle.net/21.11116/0000-0006-57F8-1

Genre: Patent

ausblenden:

Urheber:
Seeberger, Peter H.¹, Autor

Affiliations:
1Peter H. Seeberger - Vaccine Development, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society, ou_1863308

Inhalt

einblenden:

ausblenden:

Schlagwörter: -

Zusammenfassung: The present invention provides a stable synthetic saccharide of Hib polyribosylribitol- phosphate (PRP) derivative and conjugate thereof. Said saccharide, said conjugate and pharmaceutical compositions thereof are hydrolysis-resistant, long-term stable and useful for the prevention and/or treatment of diseases associated with Haemophilus influenzae, and more specifically of diseases associated with Haemophilus influenzae type b, preferably diseases selected from meningitis, pneumonia, and epiglotitis. They have general formula (I): wherein A is formula (II) or formula (III); B is formula (IV); C is formula (V); D is formula (VI); E is formula (VII); F is formula (VIII) or formula (IX).